- $15.34m
- $21.38m
- $0.07m
2019 March 31st | 2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0.013 | 0.166 | 0.072 |
Cost of Revenue | |||||
Gross Profit | — | — | -0.623 | 0.074 | -1.46 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.023 | 5.82 | 10.8 | 14.9 | 10.4 |
Operating Profit | -0.023 | -5.82 | -10.8 | -14.8 | -10.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.023 | -6.61 | -11.5 | -15.5 | -10.7 |
Net Income After Taxes | -0.023 | -6.61 | -11.5 | -15.5 | -10.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.023 | -6.61 | -11.5 | -15.5 | -10.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.023 | -6.61 | -11.5 | -15.5 | -10.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0 | -0.054 | -0.104 | -0.169 | -0.081 |